Suppr超能文献

棕榈酰化控制 NMDA 受体功能和类固醇敏感性。

Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.

机构信息

Institute of Physiology CAS, Prague 4, 142 20, Czech Republic.

Third Faculty of Medicine, Charles University in Prague, Prague 10, 100 00, Czech Republic.

出版信息

J Neurosci. 2021 Mar 10;41(10):2119-2134. doi: 10.1523/JNEUROSCI.2654-20.2021. Epub 2021 Feb 1.

Abstract

NMDARs are ligand-gated ion channels that cause an influx of Na and Ca into postsynaptic neurons. The resulting intracellular Ca transient triggers synaptic plasticity. When prolonged, it may induce excitotoxicity, but it may also activate negative feedback to control the activity of NMDARs. Here, we report that a transient rise in intracellular Ca (Ca challenge) increases the sensitivity of NMDARs but not AMPARs/kainate receptors to the endogenous inhibitory neurosteroid 20-oxo-5β-pregnan-3α-yl 3-sulfate and to its synthetic analogs, such as 20-oxo-5β-pregnan-3α-yl 3-hemipimelate (PAhPim). In cultured hippocampal neurons, 30 μm PAhPim had virtually no effect on NMDAR responses; however, following the Ca challenge, it inhibited the responses by 62%; similarly, the Ca challenge induced a 3.7-fold decrease in the steroid IC on recombinant GluN1/GluN2B receptors. The increase in the NMDAR sensitivity to PAhPim was dependent on three cysteines (C849, C854, and C871) located in the carboxy-terminal domain of the GluN2B subunit, previously identified to be palmitoylated (Hayashi et al., 2009). Our experiments suggested that the Ca challenge induced receptor depalmitoylation, and single-channel analysis revealed that this was accompanied by a 55% reduction in the probability of channel opening. Results of modeling indicate that receptor palmitoylation promotes anchoring of the GluN2B subunit carboxy-terminal domain to the plasma membrane and facilitates channel opening. Depalmitoylation-induced changes in the NMDAR pharmacology explain the neuroprotective effect of PAhPim on NMDA-induced excitotoxicity. We propose that palmitoylation-dependent changes in the NMDAR sensitivity to steroids serve as an acute endogenous mechanism that controls NMDAR activity. There is considerable interest in negative allosteric modulators of NMDARs that could compensate for receptor overactivation by glutamate or gain-of-function mutations in neurodevelopmental disorders. By a combination of electrophysiological, pharmacological, and computational techniques we describe a novel feedback mechanism regulating NMDAR activity. We find that a transient rise in intracellular Ca increases NMDAR sensitivity to inhibitory neurosteroids in a process dependent on GluN2B subunit depalmitoylation. These results improve our understanding of the molecular mechanisms of steroid action at the NMDAR and indeed of the basic properties of this important glutamate-gated ion channel and may aid in the development of therapeutics for treating neurologic and psychiatric diseases related to overactivation of NMDARs without affecting normal physiological functions.

摘要

N-甲基-D-天冬氨酸受体(NMDARs)是配体门控离子通道,可导致钠离子和钙离子流入突触后神经元。由此产生的细胞内钙离子瞬变引发突触可塑性。如果持续时间延长,可能会引起兴奋性毒性,但也可能激活负反馈来控制 NMDARs 的活性。在这里,我们报告细胞内钙离子的短暂上升(钙离子挑战)会增加 NMDARs 对内源性抑制性神经甾体 20-氧代-5β-孕烷-3α-基 3-硫酸盐及其合成类似物如 20-氧代-5β-孕烷-3α-基 3-半琥珀酸酯(PAhPim)的敏感性,但不会增加 AMPARs/KA 受体的敏感性。在培养的海马神经元中,30μm 的 PAhPim 对 NMDAR 反应几乎没有影响;然而,在钙离子挑战后,它抑制了 62%的反应;同样,钙离子挑战诱导重组 GluN1/GluN2B 受体上的甾体 IC 降低了 3.7 倍。NMDAR 对 PAhPim 的敏感性增加取决于 GluN2B 亚基羧基末端结构域中的三个半胱氨酸(C849、C854 和 C871),这些半胱氨酸先前被鉴定为棕榈酰化(Hayashi 等人,2009)。我们的实验表明,钙离子挑战诱导受体去棕榈酰化,单通道分析显示,这伴随着通道打开概率降低 55%。建模结果表明,受体棕榈酰化促进 GluN2B 亚基羧基末端结构域与质膜的锚定,并促进通道打开。去棕榈酰化诱导的 NMDAR 药理学变化解释了 PAhPim 对 NMDA 诱导的兴奋性毒性的神经保护作用。我们提出,NMDAR 对甾体的棕榈酰化依赖性敏感性变化是一种急性内源性机制,可控制 NMDAR 活性。人们对 NMDAR 的负变构调节剂产生了浓厚的兴趣,这些调节剂可以补偿谷氨酸或神经发育障碍中功能获得性突变引起的受体过度激活。通过电生理学、药理学和计算技术的组合,我们描述了一种调节 NMDAR 活性的新的反馈机制。我们发现,细胞内钙离子的短暂上升会增加 NMDAR 对抑制性神经甾体的敏感性,这一过程依赖于 GluN2B 亚基的去棕榈酰化。这些结果提高了我们对 NMDAR 中甾体作用的分子机制的理解,实际上也提高了对这种重要的谷氨酸门控离子通道的基本特性的理解,并可能有助于开发治疗与 NMDAR 过度激活相关的神经和精神疾病的治疗方法,而不会影响正常的生理功能。

相似文献

1
Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.棕榈酰化控制 NMDA 受体功能和类固醇敏感性。
J Neurosci. 2021 Mar 10;41(10):2119-2134. doi: 10.1523/JNEUROSCI.2654-20.2021. Epub 2021 Feb 1.
9
Access of inhibitory neurosteroids to the NMDA receptor.抑制性神经甾体对 NMDA 受体的作用。
Br J Pharmacol. 2012 Jun;166(3):1069-83. doi: 10.1111/j.1476-5381.2011.01816.x.

引用本文的文献

4
Limb-Clasping Response in NMDA Receptor Palmitoylation-Deficient Mice.NMDA 受体棕榈酰化缺陷小鼠的肢体夹持反应。
Mol Neurobiol. 2024 Nov;61(11):9125-9135. doi: 10.1007/s12035-024-04166-9. Epub 2024 Apr 9.
7
NMDA Receptor and Its Emerging Role in Cancer.NMDA 受体及其在癌症中的新作用。
Int J Mol Sci. 2023 Jan 28;24(3):2540. doi: 10.3390/ijms24032540.
10
Ion channels and channelopathies in glomeruli.离子通道与肾小球中的通道病。
Physiol Rev. 2023 Jan 1;103(1):787-854. doi: 10.1152/physrev.00013.2022. Epub 2022 Aug 25.

本文引用的文献

8
UniProt: a worldwide hub of protein knowledge.UniProt:蛋白质知识的全球枢纽。
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515. doi: 10.1093/nar/gky1049.
9
Structure, function, and allosteric modulation of NMDA receptors.NMDA 受体的结构、功能和别构调节。
J Gen Physiol. 2018 Aug 6;150(8):1081-1105. doi: 10.1085/jgp.201812032. Epub 2018 Jul 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验